Biochemists have developed a new method to identify pharmaceutical candidates more quickly. This advancement is part of a broader trend of using technologies such as artificial intelligence and machine learning to accelerate drug discovery, with potential applications in areas like cancer and infectious disease treatment. The use of computational approaches and tools like CRISPR is also being explored to streamline the drug discovery process.